| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to medicine, particularly to ophthalmology, namely to medicinal product for treating dry eye syndrome. The medicinal product contains polyvinyl pyrrolidone, sodium chloride, potassium chloride, calcium chloride, magnesium chloride, sodium hydrocarbonate, dexamethasone phosphate, dextrose and water for injections.EFFECT: medicinal product increases the clinical effectiveness in dry eye syndrome and is free from side effects, and can be used in various degrees of severity of dry eye syndrome; it has no limitations of duration of use and absolute contraindications.2 ex |
